# 🧬 CGT 每日情报 (Daily Brief)
> **日期**: 2026-02-13 | **更新时间**: 06:58 (北京时间)
> **监控范围**: Global (In vivo/FDA) & China (NMPA/Biotech)

---

## 🌍 全球前沿 (FDA / In vivo / MNCs)
- `[20:05]` **CareDx 公布 AlloHeme™ 的临床验证结果，这是首个用于 AML 和 MDS 细胞后治疗的人工智能支持的 NGS 监测解决方案**
  <br><small>🇬🇧 *CareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and MDS Post‑Cell Therapy* [🔗Source](https://news.google.com/rss/articles/CBMingJBVV95cUxNWnpxTllBUWgxc2M2bURTNFd0ajEyZXhIUzFELU11am9zbDVUVDl5MTZjb280ZnRSNDhvTEFfVjRwTEpPMXp1Y3RveWRfNHl4YUxIeVUwN2szZHJsd0NybEdIWlhZTG50ZjVOUFNwZ05od2tPbmFNRnRZZnJIalhFWVN5MWlROVdqZTV4ODhnT0VhbTdxQ25qYlA1Z0RiUkVTNUt5Vm5GNkRJZFBkVi1hdjlZRFpORnV2YkRQSTdVSzkzdEhvVjFweTNNSnpnSHd2V21zUFhrc0JTUWRlUERybjQ1dmlUTDdrYzF2UlZRZGpSVE1OOFBSUVloNENWYzJDSTJGelFZelpRUnlWYXFMNWJpenMxamdsRVVaalBn?oc=5)</small>

---

## 🇨🇳 中国动态 (NMPA / Domestic Players)
- `[17:52]` **转载丨莱芒生物：代谢增强型CAR-T疗法，实现细胞治疗颠覆性突破** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE5UQW9PbWJFMTk0V0tnOHAzbTg2WFBFd1lOWXR1NDBfQ3JEcjNKVm03ZWY1N0hrNGV3RmU2eGN3Rkc1djRub1pQUzQ1SVFNSDBHVEptOERjcFd5cFJCeDJkSUk4cTJyaTdLTVJzS09pQlU2WWNHUzFMZmdVc3BEQQ?oc=5)
- `[15:44]` **AAV体内制备CAR-T新突破** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE84LUc3a2NLdkJyWng4TFBJbzMxZ1UwRTZDRGh2TTR6TU0waWRKcjUzc291azN4ZTFTbDVETTc1ek1HVERRRDBZalllbHUzWjBudjhFdTZkdFZxakdNUGNRYzN1OVBTYUtOa0xxZWZ6RGYyRWRLUW5rOHZYaXhpQQ?oc=5)
- `[09:02]` **澳大利亚细胞和基因治疗产品（CAGT）的临床开发** [🔗阅读原文](https://news.google.com/rss/articles/CBMigAFBVV95cUxQS0lyM3hqMEhpMEpVeDh0U2VVOGdIZTF4RVJMYU1qdTlUdmZKYzctTUp2RkJEbzNwVzN6TUVwSnFXVElWMjVzeF9xdktVbml1SGRwLWM2SkNRd1FueVNVMmVTYzg0aDRkdUF5RUJ1emtmaWhmbG5ZeTZobmJBdjktaw?oc=5)
